Neostigmine antagonizes non-depolarizing blockade by all of the following mechanisms except.
**Core Concept**
Neostigmine is an anticholinesterase agent used to reverse non-depolarizing neuromuscular blockade. It works by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine at the neuromuscular junction.
**Why the Correct Answer is Right**
Neostigmine reverses non-depolarizing blockade by increasing the concentration of acetylcholine at the neuromuscular junction, which competitively antagonizes the non-depolarizing muscle relaxants. This is achieved through the inhibition of acetylcholinesterase, allowing more acetylcholine to bind to the nicotinic receptors on the muscle surface. This process is mediated through the muscarinic and nicotinic receptors, which are responsible for the indirect action of neostigmine on the neuromuscular junction.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a known mechanism of neostigmine in reversing non-depolarizing blockade.
**Option B:** This option is incorrect because it is not a known mechanism of neostigmine in reversing non-depolarizing blockade.
**Option D:** This option is incorrect because it is not a known mechanism of neostigmine in reversing non-depolarizing blockade.
**Clinical Pearl / High-Yield Fact**
It is essential to note that neostigmine can cause muscarinic side effects such as bradycardia, salivation, and sweating, which can be managed with anticholinergic agents like atropine.
**Correct Answer:** A.